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Abstract
Visceral fat (VF) promotes the development of metabolic syndrome (MetS), which emerges as early as in adolescence. The
clustering of MetS components suggests shared etiologies, but these are largely unknown and may vary between males and
females. Here, we investigated the latent structure of pre-clinical MetS in a community-based sample of 286 male and 312
female adolescents, assessing their abdominal adiposity (VF) directly with magnetic resonance imaging. Principal
component analysis of the five MetS-defining variables (VF, blood pressure [BP], fasting serum triglycerides, HDL-cholesterol
and glucose) identified two independent components in both males and females. The first component was sex-similar; it
explained .30% of variance and was loaded by all but BP variables. The second component explained .20% of variance; it
was loaded by BP similarly in both sexes but additional loading by metabolic variables was sex-specific. This sex-specificity
was not detected in analyses that used waist circumference instead of VF. In adolescence, MetS-defining variables cluster
into at least two sub-syndromes: (1) sex-similar metabolic abnormalities of obesity-induced insulin resistance and (2) sex-
specific metabolic abnormalities associated with BP elevation. These results suggest that the etiology of MetS may involve
more than one pathway and that some of the pathways may differ between males and females. Further, the sex-specific
metabolic abnormalities associated with BP elevation suggest the need for sex-specific prevention and treatment strategies
of MetS.
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Introduction
Metabolic syndrome (MetS) is defined as a cluster of risk factors
for cardiovascular disease (CVD) and type-2 diabetes mellitus
(T2DM) occurring in the same individual; it includes elevated
blood pressure (BP), atherogenic dyslipidemia (raised triglycerides
[TG] and lowered HDL-cholesterol [HDL-chol]), raised fasting
glucose (Glu) and abdominal obesity. For diagnostic purposes,
MetS is defined by the presence of at least three out of these five
risk factors [1]. The syndrome is associated with a two-fold
increase for the risk of CVD and a five-fold increase for the risk of
T2DM [2]. Therefore, it is alarming to see that the prevalence of
MetS is reaching epidemic proportions worldwide. In Canada and
USA, for example, .25% of adults suffer from the syndrome
[3,4,5]. Moreover, MetS, typically regarded as a middle- to late-
adulthood disorder, is now emerging in adolescence [6] with close
to 10% of all 12–19-year olds being affected [7,8]. This emergence
of MetS in adolescence has been in part attributed to obesity; it is
one of the components as well as the main risk factor for MetS,
and its prevalence has tripled during the last 30 year in this age
group [9,10].
Obesity-related risk for MetS increases not only with the
quantity of body fat but also with its distribution – individuals who
store body fat viscerally rather than elsewhere in the body are at a
greater risk [11,12,13]. Abdominal obesity is typically assessed
with a readily available waist circumference (WC), that reflects not
only the quantity of fat but also the quantity of lean body mass
(muscles, bones and internal organs) and cannot distinguish
between subcutaneous and visceral fat. As such, WC may
misclassify visceral obesity: there are individuals who have a
normal WC but an excessive amount of VF and high risk for
MetS, and individuals who have a large WC but a normal amount
of VF and low risk for MetS [14].
Despite the critical role of VF in MetS pathogenesis and the
recent emergence of MetS in adolescence, only a few large-scale
population-based studies quantified VF directly (with magnetic
resonance imaging [MRI] or computed tomography) [11,12,15];
none of them were conducted in adolescents. Furthermore, sex
differences exist in the prevalence of some MetS components and
in certain relationships between MetS-defining variables. For
example, hypertension is more common in men than women [16]
and VF is more closely correlated with BP in males than females
PLOS ONE | www.plosone.org 1 December 2013 | Volume 8 | Issue 12 | e82368
[11,17,18]. Therefore, the aim of the present study was to examine
the clustering of VF (measured directly using MRI) with other
MetS-defining variables in community-based samples of males
(n = 286) and females (n = 312) during adolescence, when the
initial stages of MetS (‘‘pre-clinical’’ disease [19]) may be
emerging.
Methods
Ethics Statement
Written consent of the parents and assent of the adolescents
were obtained before the commencement of data collection. The
Research Ethics Committee of the Chicoutimi Hospital and the
Hospital for Sick Children in Toronto approved the study
protocol.
Participants
Caucasian male (n = 286) and female (n = 312) adolescents aged
12 to 18 years were recruited from the French-Canadian
population living in the Saguenay-Lac St. Jean region of Quebec,
Canada, as part of the Saguenay Youth Study (SYS). The SYS is a
population-based, cross-sectional study of cardiovascular, meta-
bolic and brain health in adolescence. All participants were
recruited through local high schools, as we described previously
[20]. The current sample consists of participants recruited and
tested between November 2003 and June 2009.
Assessments
All participants underwent a 15-hour cardiovascular, metabolic
and brain phenotyping protocol, which included assessments of all
five MetS-defining variables [20].
Abdominal obesity was assessed with MRI and by measuring
WC. MRI was used to measure volume of VF. MRI is currently
the only non-invasive (i.e. without radiation) method that can
measure VF directly in population-based studies of children and
adolescents [21,22]. T1-relaxation time for adipose tissue is much
shorter than that of most other tissues, and thus T1-weighted MRI
produces images on which fat is very bright and easy to segment
by semi-automated or automated techniques [23]. In the present
study, volume of VF was measured with a semi-automated
technique [24] from a 10-mm-thick (in-plane resolution
1.5661.56 mm2) axial T1-weighted image (repetition time/echo
time= 200 ms/20 ms) acquired at the level of the umbilicus on a
Phillips 1.0-T magnetic resonance scanner. In more detail, images
were smoothed using an adaptive bilateral filter to remove image
noise while preserving edge information. An initial fat-classifica-
tion map was obtained using a standard region-growing algorithm.
An iterative refinement procedure corrected false positives and
false negatives using a battery of morphological operators,
including hysteresis, thresholding over small neighborhoods and
median filtering to remove salt and pepper noise. The resulting
classification map was manually segmented into VF, which was
defined as adipose tissue lying within the innermost aspect of the
abdominal cavity, and not contained within other abdominal
organs or muscles. A histogram counting algorithm computed the
total number of voxels for VF. This semi-automated method was
validated against manual segmentation in 20 randomly selected
subjects (r2 = 0.97), as described previously [17]. In addition,
height and weight were measured using standard operating
procedures [20] and BMI was calculated as weight (in kilograms)
divided by height (in meters) squared.
BP was measured beat-by-beat during a 52-min cardiovascular
protocol designed to mimic daily life activities, such as changes in
posture and mental stress. This protocol included a succession of
three 10-min periods when participants were in supine, standing
and sitting positions, which was followed by a 2-min math-stress
and 10-min stress-recovery periods (both in a sitting position). The
recording was made with a non-invasive hemodynamic monitor
FinometerTM (FMS Finapres, Amsterdam, The Netherlands); the
device measures finger blood-flow continuously and, from these
data, it derives beat-by-beat brachial BP using the reconstruction
and level-correction of the finger blood-flow waveform. The
FinometerTM is a reliable device for tracking BP in adults and
children older than six years [25]. Averages of systolic BP (SBP)
during the five sections of the cardiovascular protocol described
above (supine, standing, sitting, mental stress and mental stress
recovery) were used for statistical analyses. We chose to study SBP
because (1) systolic rather then diastolic hypertension is predom-
inant among obese children [26] and young adults [27], and (2)
population variance in SBP vastly exceeds that in diastolic BP [28].
Serum concentrations of TG, HDL-chol and Glu were
measured from a blood sample drawn between 8 AM and 9 AM
after overnight fasting; the measurements were made at the clinical
Biochemistry Department of the Hoˆtel-Dieu Hospital (Montreal,
Quebec, Canada).
In the present study, we defined MetS according to the
recommendations of the International Diabetes Federation; the
panel proposes that, for age 10 to ,16 years, adult criteria are
used for BP, TG, HDL-chol and Glu and age-specific criteria are
used for waist circumference [29], and, for age $16 years, adult
criteria are used for all components of MetS [1,6]. The exact cut-
off values are provided in Table S1. The prevalence of MetS was
2.9% in males and 1.3% in females (Table S1), which is
comparable to that reported previously [7].
Statistical Methods
Descriptive statistics used to characterize the study population
included means and standard deviations (SDs) for continuous
variables and proportions for categorical variables (presented in
Table 1). Our main analyses focused on examining the architec-
ture of pre-clinical MetS by identifying components of shared
variance using principal component analysis (PCA) of the five
MetS-defining variables, namely SBP, fasting serum TG, HDL-
chol, Glu and VF. We also examined whether the components of
shared variance differ when VF is replaced with WC. Prior to
PCA, we assessed the normality assumption on which the
statistical inference about PCA relies. VF, WC and serum TG,
HDL-chol and Glu had positively skewed distributions and were
log transformed using logarithm with base 10, which improved the
fit. Before conducting PCA, all variables were adjusted for age
and, in the case of VF, WC and SBP also for height. Age and
height are known to correlate with BP in children and adolescents
[30,31].
PCA was used to identify components of shared variance among
the five MetS-defining variables described above. To examine
whether these components vary across the cardiovascular protocol,
the analysis was repeated for each of the five sections protocol (i.e.,
supine, standing, sitting, stress and stress recovery). PCA is a
multivariate statistical technique that transforms a number of
possibly correlated variables into a number of uncorrelated
variables, so called principal components [32]. Each principal
component represents a different linear combination of the
original correlated variables. The original variables are first
normalized to their respective means and, then used to generate
a correlation matrix (Tables S2 and S3). PCA is then performed by
eigenvalue decomposition of the correlation matrix. Principal
components with eigenvalue.1 and loadings of individual MetS
variables $0.3 were considered significant, as suggested previously
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for data with sample size $100 [33]. These analyses were done in
males and females both separately and together, in the latter case
adjusting for sex (JMP, Release 9, SAS Institute Inc., Cary, NC).
Results
PCA of the five MetS-defining variables (SBP, fasting serum
TG, HDL-chol, Glu and VF) identified two independent
components of shared variance in both males and females. The
first component, PC1, explaining ,30% of total variance, was almost
identical in males and females. In both sexes, it was loaded by all
MetS-defining variables except for SBP; VF, TG and Glu
contributed positively and HDL-chol contributed negatively
(Figure 1A). As pointed out above, this component did not involve
SBP; this was the case across all five sections of the cardiovascular
protocol (i.e., supine, standing, sitting, stress and post-stress) in
both males and females (Figure 1A).
In contrast, the second component, PC2, explaining ,20% of total
variance, was loaded mainly by SBP in both sexes but, at the same
time, SBP clustered with other MetS-defining variables differently
in males and females. In males, SBP clustered positively with VF
and HDL-chol. In females, SBP clustered positively with TG and
negatively with Glu (Figure 1A). In both sexes, the clustering
remained relatively constant throughout the cardiovascular
protocol, except for the supine section when the contribution of
HDL-chol in males was weaker (Figure 1A).
In most population-based studies, ‘‘abdominal obesity’’ is
measured indirectly with WC. Therefore, we explored whether
clustering of the five MetS-defining variables differs when WC is
used instead of VF. In these analyses, the first component, PC1,
remained similar, but the second component, PC2, changed
(Figure 1B [WC]; compare with Figure 1A [VF]). In males, SBP
no longer clustered with ‘‘abdominal obesity’’ and HDL-chol, but
it did with ‘‘abdominal obesity’’ (represented here by WC) alone.
In females, SBP no longer clustered with TG and Glu, but it did
with HDL-chol and Glu (Figure 1B; compare with Figure 1A).
Overall, sex differences of this component became less pro-
nounced (Figure 1B; compare with Figure 1A).
Further, a potentially confounding effect of sex is frequently
accounted for by adjusting statistically for sex. But this simple
statistical treatment may not account for the existing biological
differences between males and females [18]. To explore this issue,
we performed sex-pooled analyses adjusted for sex, and compared
them with the sex-specific analyses described above. These sex-
pooled analyses showed that, as expected, the first component
(PC1), which was similar in males and females in the sex-specific
analyses, remained almost the same in the sex-pooled analysis
(Figure 1A). But the second component (PC2), which was different
in males and females in the sex-specific analyses, changed in that
SBP did not cluster with any metabolic component (Figure 1A).
This is likely due to the fact that the sex-specific metabolic
correlates of SBP were often of the opposing relationship in males
and females; for example, TG loaded positively in females but this
variable loaded negatively in males (Figure 1A). In the pooled
analyses, these sex-specific relationships canceled each other out.
Table 1. Basic characteristics and main outcomes in studied adolescent males and females.
Characteristic/Outcome Males Females P-value
N Mean±SD/N N Mean±SD/N
Age (years) 286 15.061.8 310 15.161.9 0.37
Height (cm) 281 167.0610.6 306 160.166.6 ,0.001
Weight (kg) 274 59.0613.8 307 54.8610.6 ,0.001
BMI (kg/m2) 276 21.263.8 306 21.463.6 0.64
BMI (log kg/m2) 276 1.3260.07 306 1.3260.07 0.60
Visceral fat (cm3)* 276 27.1628.4 296 23.4616.9 0.70
Visceral fat (log cm3) 276 1.2560.38 296 1.2660.29 0.60
Waist circumference (cm)* 273 72.868.9 306 69.468.1 ,0.001
Waist circumference (log cm) 273 1.8660.05 306 1.8460.05 ,0.001
Supine SBP (mm Hg) 236 118.9611.5 263 118.2610.2 0.50
Standing SBP (mm Hg) 233 125.1613.7 259 120.1612.2 ,0.001
Sitting SBP (mm Hg) 237 125.4613.6 262 120.2611.9 ,0.001
Math SBP (mm Hg) 235 140.3616.8 260 133.3615.1 ,0.001
Post-math SBP (mm Hg) 234 128.0612.6 259 123.8612.2 ,0.001
Triglycerides (mmol/L)* 253 1.0260.46 277 1.0760.45 0.12
Triglycerides (log mmol/L) 253 20.0360.19 277 20.0160.18 0.16
HDL-cholesterol (mmol/L)* 254 1.4060.28 277 1.5660.32 ,0.001
HDL-cholesterol (log mmol/L) 254 0.1460.09 277 0.1860.09 ,0.001
Glucose (mmol/L)* 254 4.8060.42 275 4.6460.43 ,0.001
Glucose (log mmol/L) 254 0.6860.04 275 0.6660.04 ,0.001
Fasting insulin (pmol/L) 243 67.6630.5 266 78.4628.8 ,0.001
BMI: body-mass index. Non-adjusted means and standard deviations are presented. Sex differences were evaluated with Student T-test or with non-parametric Wilcoxon
test when data were not normally distributed*.
doi:10.1371/journal.pone.0082368.t001
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Discussion
The results of the present study demonstrate that the five MetS-
defining variables cluster into at least two independent compo-
nents of shared variance in both male and female adolescents. The
first component, capturing the variance related to obesity-related
insulin resistance, is similar in males and females, whereas the second
component, capturing the variance associated with metabolic
correlates of BP, is different in the two sexes. These results suggest
that the etiology of MetS may involve more than one underlying
pathway and that some of the pathways may differ in males and
females.
In the present study, the first component of shared variance
among the five MetS-defining variables was loaded positively by
VF, TG and Glu and negatively by HDL-chol; BP did not load on
this component at all. This component was the same in male and
female adolescents. The loading of this component is consistent
with the classical clustering of metabolic variables due to obesity-
induced insulin resistance, whereby excess VF (a) increases peripheral
and hepatic insulin resistance, which in turn augments fasting
glycemia, and (b) promotes the development of atherosclerotic
dyslipidemia, characterized by increased TG and decreased HDL-
chol [1,34]. In more detail, fat tissues secrete adipokines, such as
TNFa and free fatty acids, which when released into the
circulation enhance insulin resistance in skeletal muscle and liver
[35]. Assuming some degree of failure of pancreatic b-cells, this
leads to higher fasting glycemia. In addition, augmented lipid flux
from fat tissues to the liver increases TG through augmented liver
production of very-low density lipoproteins (VLDL), which are
particles rich in TG. Increased TG, in turn, activate cholesteryl
ester transfer protein, which is a plasma protein facilitating the
transport of cholesteryl esters and TG between lipoproteins; it
collects TG from VLDL and exchanges them for cholesteryl esters
from HDL (and vice versa). This process results in TG enrichment
of HDL and, at the same time, a decrease of cardio-protective
HDL-chol [36]. As pointed out above, this cluster of obesity-induced
insulin resistance was remarkably similar in males and females and
remained virtually unchanged (a) when VF was replaced with WC
as a measure of ‘‘abdominal obesity’’ and (b) when the two sexes
were analyzed together and a potentially confounding effect of sex
was accounted for by statistical adjustment for sex. These results
suggest that the component is not specific to VF only and it is not
influenced by sex. They are consistent with previous factor
analyses of MetS in adults demonstrating the existence of sex-
similar clustering of various obesity measures with insulin
resistance and lipid abnormalities [37,38].
In contrast, the second component of shared variance among
the five MetS-defining variables was different in each sex and in
sex-pooled analyses, and differed also when VF was replaced with
WC as a measure of ‘‘abdominal obesity’’. Although BP loaded
into this component in all these analyses, the clustering of BP with
additional metabolic variables varied. In males, BP clustered
positively with VF and HDL-chol, whereas in females, it clustered
positively with TG and negatively with Glu. In sex-pooled
analyses, BP no longer clustered with any metabolic component,
possibly due to the fact that the sex-specific metabolic correlates of BP
were often of the opposing relationship with BP in males and
females.
The sex-specific clustering of BP with MetS-defining metabolic
variables suggests the existence of sex-specific mechanisms of BP
regulation. This is consistent with the fact that BP is a sexually
dimorphic trait, with both BP and the prevalence of hypertension
being higher in males than females during reproductive age,
beginning in early adolescence [39,40]. In the present study, BP
clustered positively with VF in males but not females. This sex
difference in the relationship of VF to BP is not very well
understood but it may, in part, be related to obesity-induced
sympathoactivation. Sympathoactivation, which is one of the key
mechanisms of BP elevation in obesity [41] is closely related to the
quantity of VF [42] but not subcutaneous fat [43] and, in
adolescence, VF-related sympathoactivation is seen in males but
not females [17].
In the present study, BP also clustered with MetS-defining lipid
variables (TG and HDL-chol) in a sex-specific manner. In females
only, it clustered positively with TG, which is a finding consistent
with studies demonstrating that acute administration of TG
increases BP in animals and humans [44,45]. In males only, it
clustered positively with HDL-chol. Classically, high-density
lipoproteins (HDL) have BP-lowering effects [46,47]; however, in
MetS and other cardiometabolic disease states, some of these
protective properties of HDL may be lost due to structural changes
of HDL [48,49]. It is, perhaps, this fraction of so called
‘‘dysfunctional’’ HDL that contributes to the positive relationship
between HDL-chol and BP observed in males.
Finally, BP also clustered with Glu in a sex-specific manner.
The relationship was negative and was present only in females.
Glu is an index of impaired glucose tolerance that develops due to
insulin resistance (and pancreatic b-cell dysfunction). The inverse
relationship between Glu and BP in females may result from the
action of a molecule that (a) has both insulin-sensitizing (Glu-
lowering) and fluid retentive (BP-elevating) effects and (b) shows
higher expression/activity in females than males. One such
molecule may be PPARc: it has both insulin-sensitizing [50] and
fluid-retentive [51,52,53] effects, and some of its actions are more
pronounced in women than men [54]. PPARc is a transcription
factor expressed mainly in adipose tissue (but also in the kidneys)
where it plays a key role in promoting adipogenesis as part of its
insulin-sensitizing actions [55]. Enhanced adipogenesis, in turn,
contributes to accelerated weight gain that occurs at later stages of
pubertal development and is more pronounced in females than
males [56]. Further experimental studies are required to support
the possible role PPARc in mediating the inverse relationship
between BP and Glu and whether this relationship is specific to the
later stages of puberty studied here (Table 1).
The current study is a cross-sectional investigation and, as such,
no causal conclusions can be drawn. A longitudinal design would
facilitate examination of causal relationships between, e.g.,
metabolic variables and BP, and their predictive value vis-a`-vis
the emergence of a full-blown MetS. Usefulness of cross-sectional
studies, however, should not be underestimated, as they have
generated many clinically highly relevant findings (e.g., NHANES
III [7], Framingham Study [57] and Bogalusa Heart Study [58].
Figure 1. Clustering of MetS-defining variables with visceral fat or waist circumference. Principal component analysis (PCA) was
performed with either visceral fat (VF) or waist circumference (WC) and remaining four MetS-defining variables: systolic blood pressure (SBP) and
fasting serum concentrations of triglycerides (TG), HDL-cholesterol (HDL-chol) and glucose (Glu). To examine whether identified principal
components vary across the cardiovascular protocol, the analysis was repeated for each of its five sections (i.e., supine, standing, sitting, stress and
stress recovery). Principal components with eigenvalue.1 and loadings of individual MetS-defining variables $0.3 were considered significant [33].
These analyses were done in males and females separately and males and females together adjusting for sex (sex-pooled analyses). All variables were
adjusted for age and when relevant for height prior to sex-separate PCA and additionally for sex prior to sex-pooled PCA.
doi:10.1371/journal.pone.0082368.g001
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In summary, the results of the present study suggest that, in
adolescence, MetS consists of at least two sub-syndromes, one
reflecting sex-similar metabolic abnormalities of obesity-induced insulin
resistance and the other capturing sex-specific metabolic correlates of BP
elevation. The results also suggest that VF may enhance the first
sub-syndrome (obesity-induced insulin resistance) in both males and
females, whereas it may contribute to the second sub-syndrome
(BP elevation) only in males. Adolescents may be an important age
group for investigating the pre-clinical stages of MetS.
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